News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Alliances (World)
TaiGen Biotechnology Out-Licenses Taigexyn (Nemonoxacin) To Productos Científicos For The Latin American Market 8/25/2016
f-Star Announces Collaborative Agreement With Denali For The Development Of A Multispecific Antibody Platform To Deliver Therapeutics Across The Blood-Brain Barrier 8/25/2016
BioLineRx And I-Bridge Capital Establish A New Drug Development Joint Venture In China 8/25/2016
Metrion Biosciences Joins CRACK IT "DRGNET" Human Pain Research Consortium 8/23/2016
GE Healthcare Expands Cell Therapy Portfolio With License Of StemCell Technologies Inc.’ T-Cell Reagents 8/23/2016
Bayer (BAY) and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area 8/22/2016
ChemChina-Syngenta AG (SYT) $43 Billion Deal Approved by U.S. Security Panel 8/22/2016
Phyton Biotech Achieves Manufacturing Milestone With Thapsigargin, The Active Agent In Mipsagargin 8/22/2016
Following Successful First Stage In Trial: Kadimastem Signed Agreement With Medical Device Company To Expand Joint Trials Of Diabetes Therapy Using Unique Encapsulation Device 8/18/2016
Evolva Enters Partnership On Active Pharmaceutical Ingredients 8/18/2016
GE Healthcare And Sealed Air Corporation Enter An Exclusive Agreement To Deliver Film For Single-Use Bioprocess Systems 8/17/2016
Medivir (MVRBF) Licenses Rights To MIV-802 To Trek Therapeutics 8/17/2016
Siemens (SI) And InSightec Sign Agreement To Expand Access To Exablate Neuro Technology 8/15/2016
Bavarian Nordic (BAVA.CO) Announces Drug Supply Agreement With Bristol-Myers Squibb (BMY) For NSCLC Clinical Study 8/15/2016
Genmab A/S (GEN.CO) Scores $277 Million DuoBody Technology Tie-Up With Gilead (GILD) 8/11/2016
The Pacific Northwest Research Institute And Indivumed GmbH Announce Strategic Collaboration 8/11/2016
CANBridge Life Sciences Signs Agreement With Boehringer Ingelheim To Manufacture Inhibitory Antibody, CAN-017, For Esophageal Squamous Cell Cancer 8/11/2016
Bay Area's Versartis (VSAR) Strikes $165 Million Growth Hormone Deal With Teijin Limited 8/10/2016
Zhejiang Hisun Pharma Stikes Deal For China Rights To Celsion Immunotherapy 8/10/2016
Selvita Signs A Significant Collaboration With UCSF 8/9/2016
Sectra (SECTB) Awarded Dose Tracking Agreement With Premier, Inc., One Of The Largest Purchasing Organizations In The US. 8/9/2016
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging 8/9/2016
Dyadic (DYAI) Stock Tanks Amid Reports of Partnership Termination With Sanofi Pasteur (SASY.PA) 8/9/2016
Valeant (VRX) Announces Licensing Agreement With Norgine For NER1006 In U.S. And Canada 8/8/2016
CyberHeart Announces Development Agreement With National Cancer Center In Japan To Treat Cardiac Arrhythmias 8/8/2016
BioLineRx Signs Second Clinical Immuno-Oncology Collaboration Agreement To Investigate Combination Of BL-8040 And KEYTRUDA For Pancreatic Cancer 8/8/2016
Carna Biosciences Cancels Deal With Janssen Biotech (JNJ) Due to Strategy Reasons 8/5/2016
Pfizer Japan, Takeda (TKPYY) Terminate Distribution Agreement of Prevenar13 and Benefix in Japan, Effective Dec. 31, 2016 8/5/2016
Check-Cap Jumps on Deal With GE Healthcare to Develop Indigestible X-Ray Screening Capsule 8/5/2016
ScinoPharm And CVie Therapeutics Limited To Jointly Develop New Heart Failure Drug 8/5/2016
Roche (RHHBY) Terminates Deal with Inovio Pharma (INO), Inovio to Develop Hep B Immunotherapy Solo 8/3/2016
GlaxoSmithKline (GSK), Google (GOOG)'s Verily Create $715 Million Bioelectronic Medicines Firm 8/3/2016
Philogen S.p.A. Announces Collaboration With Johnson & Johnson Innovation (JNJ) 8/3/2016
MMJ PhytoTech Ltd Enters Strategic Land Package Agreement 8/3/2016
Plasticell And National University Of Ireland Initiate Cancer Stem Cell Collaboration 8/2/2016
Oramed (ORMP) Receives Additional $4 Million Milestone Payment From HTIT 8/2/2016
Advanced Accelerator Applications Announces Clinical Trial Agreement With NCI For Study Of Lutathera In Patients With Inoperable Pheochromocytoma And Paraganglioma 8/2/2016
BioAscent Discovery And Selcia Limited Collaboration Enhances Compound Cloud Online Collection With Unique Fragment Library 8/2/2016
Chi-Med to Invest Up to $50 Million in Amended Savolitinib Deal With AstraZeneca PLC (AZN) 8/1/2016
Orexigen (OREX) Announces Commercialization And Distributorship Agreement With Laboratorios Farmace´Uticos Rovi, S.A. For Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) In Spain 8/1/2016
BioLineRx Announces In-Licensing Of Liver Fibrosis Project Under Strategic Collaboration 8/1/2016
WuXi AppTec's Research Service Division Collaborates With Pelago Bioscience To Provide CETSA Based Target Engagement Assays 8/1/2016
San Diego's Pfenex (PFNX) Snags a $181 Million+ Hematological Malignancies Deal With Jazz Pharma (JAZZ) 7/29/2016
Frontage Laboratories And Jiuzhou Pharma Form JV For CDMO Of APIs 7/29/2016
Starpharma Initiates New DEP Drug Delivery Program With AstraZeneca PLC (AZN) 7/28/2016
Yuhan And Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Enter Into Exclusive License And Co-Development Agreement For 3rd -Generation EGFR-Targeted Therapy In China 7/28/2016
Aspect Imaging And frog Collaborate To Bring Innovation And Ease-Of-Use To MRI Technologies 7/28/2016
Thermo Fisher Scientific (TMO) Partners With HEALTH Biomed To Support Molecular Diagnostics Development In China 7/28/2016
Profil Institute for Clinical Research, Inc. And Shenzhen HighTide Biopharmaceutical Announce A Strategic Partnership Focused On The Development Of New Therapies For Diabetes And NAFLD/NASH 7/28/2016
PharmaVentures Ltd Advises The Baylor Scott & White Research Institute On Collaboration With Abzena And Creation Of Denceptor Therapeutics 7/28/2016
Sun Pharma (SUNPHARMA.NS), Almirall in $50 Million Psoriasis Drug Tie-Up 7/28/2016
Onxeo Signs Exclusive License Agreement With Pint Pharma For The Commercialization Of Beleodaq In PTCL In South America 7/27/2016
ASLAN Pharmaceuticals Pte Ltd Enters Service Agreement With Selexis SA For Development Of A Proprietary Cell Line For Expression Of ASLAN004 7/27/2016
Comeback Kid Cytokinetics (CYTK) Pockets $95 Million Upfront in R&D Deal With Astellas (ALPMY), Needs Results for More 7/27/2016
Merck & Co. (MRK) to Terminate Allergy Agreement With ALK-Abello A/S 7/27/2016
Axol And Metrion Biosciences Announce Research Collaboration 7/26/2016
ARTES Biotechnology And Burnet Institute Join Forces To Develop Novel Hepatitis C Vaccine 7/26/2016
Enigma Biomedical Group Signs Research Agreement With Biogen (BIIB) And Merck & Co. (MRK) For Novel Tau Imaging Agent 7/26/2016
Faron Pharmaceuticals Ltd. Enters Into An Agreement With Abzena For The Manufacture Of Clevegen 7/25/2016
Aurinia (ISA.TO) Establishes At-The-Market Facility 7/25/2016
Almac Group's Rapid Launch Services Support U.S. Approval Of Intercept Pharma (ICPT)'s First Commercial Orphan Drug Product 7/21/2016
Chugai Pharma And Galderma Pharma S.A. Announce Global License Agreement For Nemolizumab (CIM331), Novel Biologic For Skin Diseases 7/21/2016
Peptidream Announces License Of PDPS Technology To Genentech (RHHBY) 7/20/2016
Hisun In-licenses China Rights To mAb Brain Cancer Candidate 7/20/2016
A*STAR And Merck & Co. (MRK) Establish A New Research Collaboration To Advance Peptide Therapeutics 7/19/2016
Indivumed GmbH And Definiens AG Partner To Unlock The Power Of Tumor Tissue For Drug Discovery And Development 7/19/2016
Helix Biopharma (TSX:HBP) Announces Agreement In Principle With National Research Council of Canada To Collaborate On Various Immuno-Oncology Initiatives 7/19/2016
Vernalis PLC (VNLPY.PK) Achieves A Milestone In Its Oncology Collaboration With Servier 7/19/2016
CDRD Expands Global Industry Partnerships With Addition Of AstraZeneca PLC (AZN) 7/19/2016
Singlera Genomics, Fudan University Collaborate On Longitudinal Study Of 200,000 Volunteer Cohort 7/18/2016
Al Qassimi Hospital Organizes The First Gulf Retina Conference In Collaboration With Bayer (BAY) 7/18/2016
Uni-Bio Signs Up CR Zizhu To Market Recombinant Eye Treatment In China 7/15/2016
South Korea's Hanmi Pharma Will Partner With China Innovation 7/15/2016
MonoSolRx LLC And Monosol LLC, A Kuraray Company Announce IP License Agreement 7/15/2016
Amgen (AMGN) And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan 7/14/2016
Boehringer Ingelheim And University of Dundee Collaborate To Develop New Class Of Medicines 7/14/2016
Kyocera Corporation (KYO), RIKEN And Organ Technologies Launch Joint Research In Regenerative Medicine To Treat Hair Loss 7/13/2016
CytoSorbents Teams With Medial And Meditrade To Bring CytoSorb To Hungary, Czech Republic, Slovakia, And Poland 7/13/2016
RedHill Biopharma (RDHL) Announces Research Collaboration With NIH For Potential Ebola Treatment 7/13/2016
Boehringer Ingelheim And Eli Lilly (LLY) Announce Clinical Trial Collaboration In Metastatic Breast Cancer 7/13/2016
Prima Biomed (PRR.AX) Collaborates In Investigator Sponsored New Clinical Trial For IMP321 In Solid Tumors 7/13/2016
Thermo Fisher Scientific (TMO) And Dupont Nutrition & Health Extend BAX System Q7 Distribution Agreement In Western Europe For An Additional Three Years 7/12/2016
San Diego's Sorrento (SRNE) Forges €735 Million Immuno-Onco Tie-Up with Servier 7/12/2016
Already Partners, Bayer (BAY) and X-Chem Whip Up a New R&D Pact Worth $528 Million 7/12/2016
Celyad Hammers Out NKR-2 T-cell Immunotherapy Deal Worth $311.5 Million with Ono Pharma 7/11/2016
ENGOT And Tesaro (TSRO) Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial 7/11/2016
Evotec AG (EVTG.F) Awarded Contract From Antibiotic Research UK To Begin Integrated Drug Discovery Collaboration 7/11/2016
BioInvent (BOVNF) Enter Process Development And Manufacturing Collaboration With Alligator 7/8/2016
Onxeo Collaborates With Royal College of Surgeons In Ireland For Research Program On Beleodaq Derivatives 7/8/2016
Drug Industry CEOs Lead New Task Force On Brexit's Pharma Fallout 7/8/2016
Sprint Bioscience Inks Deal Worth $243 Million for PIP4K2-Program with Petra Pharma 7/7/2016
Turgut Ilaclari A.S. And Selexis SA Sign Service And Commercial Agreements To Progress Development Of Biosimilar Products 7/7/2016
Dehaier Medical (DHRM) Cooperates With China Sciences Group (Holding) Co., Ltd. To Enter China's Elderly Sleep Apnea Market 7/7/2016
The Medicines Patent Pool Signs New Round Of Generic Manufacturing Licences For HIV And Hepatitis C Treatments 7/7/2016
OSE Immunotherapeutics Forges $173 Million Autoimmune Deal with Johnson & Johnson (JNJ) 7/6/2016
Initiation Of Phase 1 Clinical Study With Novel Immuno-Oncology Candidate Triggers US$10 Million Milestone Payment From AstraZeneca PLC (AZN) 7/6/2016
Acerus (TRLPF) Completes NATESTO U.S. Transition 7/6/2016
Cerus (CERS) And CEI Announce Donation Of INTERCEPT Blood System Kits To HEMORIO For Emergency Preparedness Ahead Of The Summer Olympic Games In Rio De Janeiro 7/6/2016
TiGenix Lands $400 Million+ Crohn's Disease Deal with Pharma Giant Takeda (TKPYY) 7/6/2016
AstraZeneca PLC (AZN), Valeant (VRX) and LEO Pharma Shuffle Dermatology Rights, Potential $1 Billion in Sales at Stake 7/5/2016
Google (GOOG)'s DeepMind Tries to Spot Eye Conditions with Artificial Intelligence 7/5/2016
Therapix Signed A Binding MOU With Yissum Ltd., The Technology Transfer Company Of The Hebrew University Of Jerusalem, To Receive A License To Use A Formulation For Nasal Administration Of Cannabinoid Substances 7/5/2016
Vegalab Announces Exclusive Distribution Agreement For Taiwan With Union Chemical 7/5/2016
Sebia And Abingdon Health Ltd Sign Exclusive Global Distribution Agreement 7/5/2016
Karolinska Development AB Divests Its Holding In Clanotech AB To Rosetta Capital 7/5/2016
Takeda (TKPYY) To Partner With Altos Therapeutics To Develop Promising Compound For The Treatment Of Gastroparesis 7/5/2016
NovoCure Announces $75 Million Drawdown Under Its Term Loan Agreement Through Pharmakon Advisors 7/1/2016
PsiOxus Gets Upfront $10 Million, Ties Immuno-Oncology Clinical Pact With Bristol-Myers Squibb (BMY) 6/30/2016
Martindale Pharma Announces Extension Of Licensing Agreement With Unimedic AB To Include Emergency Care Product Portfolio 6/30/2016
Paradigm And IDB Resources Announce Exclusive PCDx Tumor Profiling Service Agreement 6/30/2016
Galmed Pharmaceuticals And Weizmann Institute of Science To Enter A Research Collaboration Agreement To Assess Aramchol Effects On Microbiome 6/30/2016
Yabao Pharmaceuticals And LFB Biomedicaments Enter Into Strategic Partnership To Deliver VIALEBEX (LFB’s Human Albumin) In China 6/30/2016
Greater Paris University Hospitals, AP-HP And IntegraGen, Inc. Agree To A Research Partnership To Develop A Common Platform For High-Throughput Sequencing 6/30/2016
Mundipharma AG Obtains Global (Ex-US) Rights To Orexo (ORXOF)’s Opioid Dependence Treatment Zubsolv (Buprenorphine And Naloxone) 6/30/2016
Sprint Bioscience Enters Into Research Collaboration On Blood Cancer 6/30/2016
Probiodrug AG And Crossbeta Biosciences Enter Into A Strategic Partnership In The Field Of Alzheimer’s Disease Biomarkers 6/30/2016
Novozymes A/S (NVZMY) And DONG Energy Enter Into Agreement On Biological Waste Sorting 6/29/2016
Giesecke & Devrient (G&D) China, Z-Smart Utilize Valencell Technology For Smartwatch Focused On Payments And Banking Customers 6/29/2016
MediGene AG (MDGEF.PK) Joins Max Delbruck Center And Charité For First Clinical TCR Study In Germany 6/29/2016
Indegene And IndigoMedical Form An Alliance To Provide Promotional/Medical Review And Approval Solutions For Biopharmaceutical Companies Across The Globe 6/29/2016
Sanofi (SNY) Inks Deal to Swap Business with Boehringer Ingelheim 6/28/2016
Marrone Bio Innovations, Inc And Groundwork BioAg Sign Seed Treatment Development Agreement 6/28/2016
XBiotech Signs Agreement With Megapharm To Market Xilonix In Israel 6/28/2016
Takeda (TKPYY) Returns Certain Molecules, Products to Amgen (AMGN) 6/27/2016
Daiichi Sankyo Enters Into Agreement With Servier Canada For Factor Xa Inhibitor Edoxaban 6/27/2016
Strategic Cooperation Agreement Reached By Dehaier Medical Systems Ltd. And Hongyuan Supply Chain Management Co., Ltd. 6/24/2016
Calixar And University Of Avignon To Launch New Research Lab Developing Innovative Chemistry For Target Discovery 6/24/2016
Cancer Genetics (CGIX) And Sayre Therapeutics Announce Distribution Agreement To Commercialize CGI’s Proprietary FDA-Cleared Tissue Of Origin (TOO) Test Throughout India And South Asia 6/23/2016
Cobra Biologics Ltd. And Alligator Bioscience Extend Drug Development Partnership 6/23/2016
Sinopharm Group Affiliate Pays $6.5 Million Milestone To Oramed (ORMP) 6/23/2016
Orig3n And Kangstem Biotech Announce Collaboration To Study Neural Stem Cells 6/21/2016
Oramed (ORMP) Announces $6.5 Million Milestone Payment From HTIT 6/21/2016
Progenics (PGNX) Signs Commercial License Agreement With Selexis SA For Use Of Proprietary Cell Line And Suretechnology Platform 6/21/2016
Hutchison China MediTech (Chi-Med) Earns $10 Million Milestone From AstraZeneca PLC (AZN) In Lung Cancer Trial 6/21/2016
Cell Medica And Baylor College of Medicine Announce Exclusive Licensing Agreement And Co-Development Partnership To Create Next Generation Cellular Immunotherapy Products For The Treatment Of Cancer 6/17/2016
Tri-Institutional Therapeutics Discovery Institute Expands Partnership With Takeda Pharmaceuticals 6/17/2016
The Clinical Trial Undertaken By Genomic Vision And Reims University Hospital To Validate A New Test For The Early Detection And Treatment Of Cervical Cancer Was Chosen For An Oral Presentation At The Eurogin Congress In Salzburg 6/17/2016
Uscom Limited Agreement With CIIC Shanghai 6/16/2016
Wilson Therapeutics Appoints Erik Penser As Liquidity Provider 6/16/2016
The Stockton Group And Syngenta AG (SYT) Have Entered Into A Global Development And Distribution Agreement For A New Biofungicide Technology 6/16/2016
Elekta Signs Exclusive U.S. Distribution Agreement With Kobold Medical For Brachytherapy Applicators 6/15/2016
Peptidream Achieves Milestone For Initiation Of Clinical Development For Bristol-Myers Squibb (BMY)’s First Collaboration Product Candidate 6/15/2016
Cardiome Pharma Corp. (COM.TO) Announces Term Loan Agreement With CRG-Managed Funds 6/15/2016
CMC Biologics Cleared For Commercial Manufacture Of CSL Behring's FDA-Approved AFSTYLA 6/15/2016
Mesoblast (MSB.AX) Stock Sinks 42% After Teva (TEVA) Withdraws from Heart Failure Trials 6/14/2016
PSR Orphan Experts And Raremark Announce Strategic Partnership In Rare Disease 6/14/2016
Integrated BioBank of Luxembourg Release: First France – Luxembourg Collaboration On Cancer Tissue Collection 6/14/2016
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial 6/14/2016
The Israeli Pharma Company Therapix, Is Joined By Five Internationally Renowned Experts, From Israel And The World, In The Field Of Psychiatry And Tourette 6/14/2016
BC Platforms To Provide Genomic Data Management Services To Monash University In Australia 6/13/2016
Innovent Biologics Expands Adimab LLC. Partnership; Second mAb Partnership In A Week 6/13/2016
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY) 6/13/2016
ICON Announces Service Agreement With Pfizer (PFE) 6/10/2016
Profil Institute for Clinical Research, Inc. And LMC Diabetes Launch Strategic Partnership To Conduct Cross-Border Multi-Site Trials In Diabetes And Metabolism 6/10/2016
BIO2016: French Firm Biose to Open U.S. HQ in Cambridge to Look for Partners 6/10/2016
Menarini Group And MSD Extends Global Partnership To The Asia-Pacific Region 6/9/2016
Profil Institute for Clinical Research, Inc. And mySugr Collaborate To Advance Evidence-Based Clinical Validation Of Diabetes Mhealth Solutions 6/9/2016
Takeda (TKPYY), Theravance Biopharma (TBPH) Strike $125 Million Deal for TD-8954 6/8/2016
Montreal InVivo Is Partnering With Canadian Clinical Trails Coordinating Centre(CCTCC) To Enhance Canada's Clinical Research Capabilities 6/8/2016
CRISPR And Anagenesis Biotechnologies Announce Strategic In-Licensing And Collaboration Agreement To Develop CRISPR/Cas9-Based Cell Therapies For Muscle Diseases 6/8/2016
Aptose Biosciences And CrystalGenomics Announce Exclusive Agreement For Non-Covalent BTK / FLT3 / AURK Inhibitor 6/8/2016
Curetis And Axonlab Sign Multi-Market European Distribution Agreement 6/8/2016
WaferGen Biosystems And Takara Bio Announce Exclusive Distribution Agreement For Japan 6/7/2016
Excelra Enters Into A Drug Repurposing Collaboration With Astellas (ALPMY) 6/7/2016
Adimab LLC. And Innovent Biologics Expand Partnership For The Discovery Of Antibodies And Bispecifics 6/7/2016
Meiogenix And Lesaffre Collaborate To Improve Industrial Yeast Strains’ Performance 6/7/2016
Boehringer IngelheimAnd Harvard Scientists Establish A Research Alliance To Find Novel Treatments For Severe Fibrotic Diseases 6/7/2016
Avita Medical Signs Deal For Distribution In Malaysia 6/7/2016
Lead Discovery Center Teams Up With Canadian McGill University In $1 Million Translational Drug Discovery Project 6/7/2016
Cobra Biologics Ltd. And Touchlight Collaborate On Production Of Next Generation DNA Constructs 6/7/2016
f-Star Announces An Agreement With CMC Biologics For Manufacture Of mAb2 Bispecific Antibodies 6/7/2016
Genedata Expands Partnership with MorphoSys To Support New Antibody Libraries and Developability Assessment 6/7/2016
Skyepharma (SKYEF) Signs Exclusive Agreement To Access Lucideon’s Abuse Deterrent Drug Delivery Technology 6/7/2016
Ultragenyx (RARE) Forges $65 Million Rare Disease Pact with Takeda (TKPYY) 6/7/2016
Merck & Co. (MRK) Partners With Array BioPharma (ARRY) And Pierre Fabre To Initiate BRAF-Mutant CRC Phase III Trial 6/6/2016
CEVEC And Paragon Bioservices Enter Into Comprehensive Collaboration To Roll Out CAP Technologies In North America 6/6/2016
The Stockton Group And Yeda Research and Development Company Ltd. Sign An Extension To Their Joint Research Agreement 6/6/2016
Fujifilm Diosynth Biotechnologies Announces Collaboration On A New 20,000-Liter Microbial Biologics Facility For Use By Its Contract Development And Manufacturing Customers 6/6/2016
EpimAb Biotherapeutics And Innovent Biologics Announce Multi-Target Bispecific Antibody Collaboration 6/6/2016
AHA And Chinese Society Of Cardiology Announce Collaboration And Next Steps In Improving Heart Attack Outcomes In China 6/6/2016
ULURU Signs Cooperation Agreement For Japan 6/3/2016
Provision Asia and Shenzhen Hairong International Medical Development Form Joint Venture To Develop Proton Centers And Cancer Centers In China 6/3/2016
Emperra Partners With The Federal Initiative "German Accelerator Life Sciences" To Expand To US 6/3/2016
AstraZeneca PLC (AZN) Unloads Gout Drug Rights to Grunenthal in $230 Million+ Deal 6/2/2016
Tiziana Life Sciences Plc Partnership With Cardiff University Researchers Wins Innovation In Healthcare Award 6/2/2016
Liomont Signs Commercial License Agreement With Selexis SA For Use Of Proprietary Cell Line And Suretechnology Platform 6/2/2016
Helsinn Group Signs Exclusive Agreement With Grünenthal Group For The Registration, Marketing, Promotion And Sales Of Akynzeo (Netupitant/Palonosetron Combo) In Chile 6/2/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact 6/1/2016
Can-Fite BioPharma (CFBI) Reaches Agreement With European Medicines Agency On Pivotal Phase III Clinical Trial With Piclidenoson (CF101) In Rheumatoid Arthritis 6/1/2016
Merus (MRUS) Signs Commercial Multi-Product License For ProBioGen AG’s Glymaxx ADCC Enhancement Technology 6/1/2016
Nanobiotix Receives U.S. $1 Million Milestone Payment From PharmaEngine, Inc. 6/1/2016
Lipidor And Cadila Pharmaceuticals Announce Agreement On Phase III Clinical Study And Joint Commercialization Of Topical Psoriasis Product 6/1/2016
AbbVie (ABBV) And Eisai Inc. (ESALF.PK) Subsidiary EA Pharma Commence Co-promotion Of Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA In The Field Of Gastrointestinal Disease 6/1/2016
The UAE Ministry Of Health And Prevention And The Emirates Diabetes Society In Partnership With AstraZeneca PLC (AZN), Reveal Diabetes Education & Support Programme Aimed At Diabetic Patients Under "Circle Of Care" 6/1/2016
CNOGA Medical Appointed ARTECH To Distribute Their Non-Invasive Medical Devices In Italy 6/1/2016
Guangzhou Link Health In $85 Million Deal For Cancer Drug From 4SC AG (VSC.F) 6/1/2016
Chugai Pharma Announces License Agreement For Recycling Antibody SA237 6/1/2016
Boehringer Ingelheim, Inventiva Ink EUR170 Million Idiopathic Pulmonary Fibrosis Deal 5/31/2016
LifeNome Inc. Release: Personal Genomics Revolution Comes To Southeast Asia 5/31/2016
ViiV Healthcare And The International Association Of Providers Of AIDS Care (IAPAC) To Collaborate On Fast-Track Cities 5/31/2016